Home
Categories
EXPLORE
True Crime
Comedy
Business
Society & Culture
Sports
Health & Fitness
Technology
About Us
Contact Us
Copyright
© 2024 PodJoint
Loading...
0:00 / 0:00
Podjoint Logo
US
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts116/v4/73/d3/bb/73d3bb87-2d83-485e-bb11-ad03a7dd7331/mza_5000764846250331610.jpg/600x600bb.jpg
Speaking of SurgOnc
Annals of Surgical Oncology and Society of Surgical Oncology
63 episodes
2 days ago
"Speaking of SurgOnc" is a podcast series brought to you by the Annals of Surgical Oncology (ASO) and the Society of Surgical Oncology(SSO). Dr. Frederick L. (Rick) Greene, ASO Deputy Editor, will explore and expand upon ideas and concepts described in articles published in the Annals of Surgical Oncology. Dr. Greene will interview authors and leading experts about topics of current importance in surgical oncology.
Show more...
Science
RSS
All content for Speaking of SurgOnc is the property of Annals of Surgical Oncology and Society of Surgical Oncology and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
"Speaking of SurgOnc" is a podcast series brought to you by the Annals of Surgical Oncology (ASO) and the Society of Surgical Oncology(SSO). Dr. Frederick L. (Rick) Greene, ASO Deputy Editor, will explore and expand upon ideas and concepts described in articles published in the Annals of Surgical Oncology. Dr. Greene will interview authors and leading experts about topics of current importance in surgical oncology.
Show more...
Science
Episodes (20/63)
Speaking of SurgOnc
ASO Series: Targeting Patient-Derived Orthotopic Gastric Cancers with a Fluorescent Humanized Anti-CEA Antibody
3 months ago
16 minutes 43 seconds

Speaking of SurgOnc
ASO Series: A Four-Arm Randomized Clinical Trial of Topical Pain Control for Sentinel Node Radiotracer Injections in Patients with Breast Cancer
4 months ago
14 minutes 18 seconds

Speaking of SurgOnc
Adjuvant Chemoradiation in Resected Biliary Adenocarcinoma: Evaluation of SWOG S0809 with a Large National Database
6 months ago
12 minutes 47 seconds

Speaking of SurgOnc
SSO2024 Abstract: Lower Social Support Predicts Higher Cortisol for Breast Cancer Patients in Disadvantaged Neighborhoods
6 months ago
15 minutes 45 seconds

Speaking of SurgOnc
Practice Patterns and Outcomes Among Surgical Oncology Fellowship Graduates Performing Complex Cancer Surgery in the United States Across Different Career Stages
7 months ago
19 minutes 44 seconds

Speaking of SurgOnc
Extent of Resection and Long-Term Outcomes for Appendiceal Adenocarcinoma: a SEER Database Analysis of Mucinous and non-Mucinous Histologies
8 months ago
14 minutes 33 seconds

Speaking of SurgOnc
Docetaxel‑Based Neoadjuvant Chemotherapy Followed by En Bloc Resection for Esophageal Adenocarcinoma: A 15‑Year Retrospective Analysis from a Regional Upper Gastrointestinal Cancer Network
9 months ago
17 minutes 34 seconds

Speaking of SurgOnc
The Landmark Series—Addressing Disparities in Breast Cancer Screening: New Recommendations for Black Women
10 months ago
14 minutes 34 seconds

Speaking of SurgOnc
Standardization of Colon Resection for Cancer: An Overview of the American College of Surgeons Commission on Cancer Standard 5.6
12 months ago
16 minutes 59 seconds

Speaking of SurgOnc
Hepatectomy Before Primary Tumor Resection as Preferred Approach for Synchronous Liver Metastases from Rectal Cancer
1 year ago
20 minutes 49 seconds

Speaking of SurgOnc
Hospital Designations and Their Impact on Guideline-Concordant Care and Survival in Pancreatic Cancer. Do They Matter?
1 year ago
17 minutes 42 seconds

Speaking of SurgOnc
Benchmarks and Geographic Differences in Gallbladder Cancer Surgery: An International Multicenter Study
1 year ago
17 minutes 17 seconds

Speaking of SurgOnc
CA19-9 Response to First-Line Neoadjuvant FOLFIRINOX and Second-Line Gemcitabine/Nab-Paclitaxel for Patients with Operable Pancreatic Cancer
1 year ago
15 minutes 33 seconds

Speaking of SurgOnc
Neuroendocrine Tumor Liver Metastases: Long-Term Follow-up Evaluation of More Than 500 Patients
1 year ago
16 minutes 8 seconds

Speaking of SurgOnc
Endocrine Therapy for Surgeons: Practical Pearls for Managing Menopausal, Bone Loss and Sexual Adverse Effects
1 year ago
17 minutes 8 seconds

Speaking of SurgOnc
Impact of the Histologic Pattern of Residual Tumor After Neoadjuvant Chemotherapy on Recurrence and Survival in Stage I–III Breast Cancer
1 year ago
15 minutes 2 seconds

Speaking of SurgOnc
Long-Term Survival in Patients Treated with Cytoreduction and Heated Intraperitoneal Chemotherapy for Peritoneal Mesothelioma at a Single High-Volume Center
1 year ago
14 minutes 29 seconds

Speaking of SurgOnc
Exploring the Potential of Artificial Intelligence in Surgery: Insights from a Conversation with ChatGPT
1 year ago
16 minutes 45 seconds

Speaking of SurgOnc
A Model to Predict Treatment Failure in Patients Undergoing Upfront Surgery for Resectable Colorectal Liver Metastases
1 year ago
12 minutes 3 seconds

Speaking of SurgOnc
Integration of Universal Germline Genetic Testing for All New Breast Cancer Patients
1 year ago
17 minutes 35 seconds

Speaking of SurgOnc
"Speaking of SurgOnc" is a podcast series brought to you by the Annals of Surgical Oncology (ASO) and the Society of Surgical Oncology(SSO). Dr. Frederick L. (Rick) Greene, ASO Deputy Editor, will explore and expand upon ideas and concepts described in articles published in the Annals of Surgical Oncology. Dr. Greene will interview authors and leading experts about topics of current importance in surgical oncology.